SynthesisBMC oral health2026
Efficacy of injectable platelet-rich fibrin and microneedling for thin gingival phenotype: a systematic review and meta-analysis.
Synthesis in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThin gingival phenotypes, characterized by a reduced gingival thickness (GT), are particularly susceptible to recession and inflammation. Injectable platelet-rich fibrin (i-PRF) and microneedling (MN) are emerging minimally invasive approaches for enhancing gingival thickness and improving periodontal health. To evaluate the efficacy of i-PRF and MN combination compared to i-PRF or MN monotherapy in the treatment of thin gingival phenotype.
methodsA comprehensive literature search was conducted across five databases with no language restrictions. Studies were selected based on predefined selection criteria that assessed primary outcomes (Gingival Thickness - GT, Width of Keratinised Tissue - KTW). Four split-mouth, prospective randomized trials involving 116 participants were included. Data from these studies were extracted individually by two reviewers, with a risk of bias assessment performed using the Cochrane RoB 2 tool. A meta-analysis was executed using RevMan Version 5.1.
resultsOf the 164 studies initially identified, four studies were eligible for inclusion and three for the meta-analysis. The combined use of i-PRF and MN showed a significant increase in GT, particularly within the first three months, compared to i-PRF alone. However, no significant differences were found for KTW across groups. The results for secondary outcomes, including clinical attachment level (CAL), probing depth (PD), and plaque index (PI) showed significant improvements, with i-PRF + MN leading to enhanced patient comfort and aesthetic satisfaction. The certainty evidence was estimated as low.
conclusioni-PRF combined with MN may provide an adjunctive benefit for increasing GT in thin periodontal phenotypes, particularly within the first three months. These results should be interpreted with considerable caution given the small number of studies included and the high risk of bias. While a modest improvement in GT was observed with the combination approach, the impact on KTW remains inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.